Latest Breaking News On - Board of directors acer therapeutics inc - Page 1 : comparemela.com

29.01.2024 - WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) - TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of . Seite 1

Boston collegeBoard of directors acer therapeutics incZevra therapeutics incStrategic financial servicesAkebia therapeutics incZiopharm oncology incGenzyme corporationAlaunos therapeutics incCandel therapeutics incCandel therapeuticsChief financial officerAkebia therapeuticsZiopharm oncologyAlaunos therapeuticsSenior vice presidentChief accounting